drugset / Trial / NCT01491009

Comparison of Remifentanil With Dexmedetomidine or Midazolam in Regards of Sedation Effectivity and Postoperative Cognitive Functions in Cystoscopies

NCT01491009

Completed 40 enrolled Gazi University
RandomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study was to compare the effects of remifentanil-dexmedetomidine and remifentanil-midazolam with mini-mental state examination (MMSE) in monitored anesthesia care (MAC) patients undergoing cystoscopy.

Timeline

Start
2006-05
Primary completion
2007-02
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.05 mg/kg Intravenous
Subject Midazolam Small molecule 0.15 mg/kg Intravenous
Background Remifentanil Small molecule 0.05 ug/kg Intravenous

Indications

No indication recorded.